Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Estradiol 4.167 microgram/hour prolonged-release vaginal ring |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 600 microgram/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 600 microgram/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 100 microgram/1 milliliter conventional release vaginal cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 100 microgram/1 milliliter conventional release vaginal cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 100 mg prolonged-release subcutaneous implant |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 100 mg prolonged-release subcutaneous implant |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol 1.04 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 1.04 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 1.56 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 1.56 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 2.5 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 2.5 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 3.13 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 3.13 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 4.17 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 4.17 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol 583 nanogram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 583 nanogram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing estradiol in subcutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing only estradiol in subcutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Polyestradiol phosphate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Estradiol |
Inferred relationship |
Some |
|
Product containing precisely elagolix sodium 300 milligram and estradiol 1 milligram and norethisterone 500 microgram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing precisely elagolix sodium 300 milligram and estradiol 1 milligram and norethisterone 500 microgram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Elagolix- and estradiol- and norethisterone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Elagolix and estradiol and norethisterone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing only elagolix and estradiol and norethisterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing elagolix and estradiol and norethisterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing precisely estradiol 1 milligram and norethisterone acetate 500 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing precisely estradiol 1 milligram and norethisterone acetate 500 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Drospirenone 500 microgram and estradiol 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol 2.083 microgram/hour and norethindrone acetate 7.083 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol 2.083 microgram/hour and norethindrone acetate 7.083 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol and medroxyprogesterone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol- and medroxyprogesterone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing precisely estradiol 10 microgram/1 each conventional release vaginal tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 10 microgram/1 each conventional release vaginal tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 1 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 1 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 1 mg and norethisterone acetate 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol 1 mg and norethisterone acetate 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Dydrogesterone and estradiol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Dydrogesterone- and estradiol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing precisely dydrogesterone 2.5 milligram and estradiol 500 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing precisely dydrogesterone 2.5 milligram and estradiol 500 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing precisely dydrogesterone 10 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing precisely dydrogesterone 10 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Dydrogesterone 5 mg and estradiol 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Dydrogesterone 5 mg and estradiol 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Dydrogesterone 10 mg and estradiol 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Dydrogesterone 10 mg and estradiol 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Fluid sample oestradiol level |
Component |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Plasma estradiol measurement |
Component |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Serum estradiol measurement (procedure) |
Component |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Implantation of estradiol implant (procedure) |
Direct substance |
True |
Estradiol |
Inferred relationship |
Some |
1 |